A research consortium whose goal is to develop the next class of semiconductor materials and devices. The consortium includes Purdue University, the University of Illinois, Pennsylvania State University, the University of Michigan, Argonne National Laboratory, the National Institute of Standards and Technology (NIST) and the National High Magnetic Field Laboratory.
ISN's charge is to pursue a long-range vision for how technology can make soldiers less vulnerable to enemy and environmental threats. The ultimate goal is to create a 21st century battlesuit that combines high-tech capabilities with light weight and comfort.
The central goals of the NCI funded MIT-Harvard CCNE are to rapidly translate recent advances in nanotechnology for use in the diagnosis and treatment of cancer, and to develop the next generation of nanomaterials for this purpose.
A cooperative effort of 8 institutions, the nanomedicine development center focuses on a model nucleoprotein machine that carries out non-homologous end joining (NHEJ) of DNA double strand breaks. This machine has a simple structure and significant clinical relevance.
The goal of the Nanomotor Drug Delivery Center is to construct a synthetic modified motor with artificial components for use in a variety of nanodevices and nanomedical applications. The center is to create liposomes and nano-structured arrays with embedded and active modified phi29 DNA-packaging motors for both passive and active transport of DNA and drugs.